Mirum Pharmaceuticals (MIRM) Other Working Capital Changes (2019 - 2026)

Mirum Pharmaceuticals' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$583000.0 for Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 42.89% year-over-year to -$583000.0 in Q1 2026; TTM through Mar 2026 was -$2.1 million, a 124.86% decrease from a year earlier, with the FY2025 full-year figure at -$1.9 million, down 142.46% from the prior year.
• Other Working Capital Changes slipped to -$583000.0 in Q1 2026 per MIRM's latest filing, from -$513000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $4.8 million in Q1 2026 and bottomed at -$3.1 million in Q3 2025.
• The 5-year median for Other Working Capital Changes is $162000.0 (2022), against an average of $740882.4.
• Across the five-year window, Other Working Capital Changes surged 60.45% in 2024 and slumped 447.17% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at -$183000.0 in 2022, then slipped by 25.14% to -$229000.0 in 2023, then increased by 6.55% to -$214000.0 in 2024, then plunged by 139.72% to -$513000.0 in 2025, then slipped by 13.65% to -$583000.0 in 2026.
• Per Business Quant, the three latest MIRM Other Working Capital Changes figures stand at -$583000.0 (Q1 2026), -$513000.0 (Q4 2025), and -$580000.0 (Q3 2025).